Literature DB >> 18371369

Chemotherapy and cancer stem cells.

Jeremy N Rich1, Shideng Bao.   

Abstract

Cancer stem cells are subsets of tumor cells defined through the capacity to initiate tumors and have been linked to therapeutic resistance. In this issue of Cell Stem Cell, Todaro et al. (2007) demonstrate that targeting tumor IL-4 sensitizes colon cancer stem cells to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18371369     DOI: 10.1016/j.stem.2007.09.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  55 in total

1.  CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Authors:  Joseph G Pressey; Marilyn C Haas; Christine S Pressey; Virginia M Kelly; Jacqueline N Parker; G Yancey Gillespie; Gregory K Friedman
Journal:  Pediatr Blood Cancer       Date:  2012-03-09       Impact factor: 3.167

Review 2.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

3.  A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.

Authors:  C M Tate; R Pallini; L Ricci-Vitiani; M Dowless; T Shiyanova; G Q D'Alessandris; L Morgante; S Giannetti; L M Larocca; S di Martino; S W Rowlinson; R De Maria; L Stancato
Journal:  Cell Death Differ       Date:  2012-04-27       Impact factor: 15.828

4.  Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells.

Authors:  Xiao-Yu Dai; Bao-Feng Zhou; Yang-Yang Xie; Jie Lou; Ke-Qiang Li
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.

Authors:  Naoko Okamoto; Mami Yasukawa; Christine Nguyen; Vivi Kasim; Yoshiko Maida; Richard Possemato; Tatsuhiro Shibata; Keith L Ligon; Kiyoko Fukami; William C Hahn; Kenkichi Masutomi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  Developmental Insights into Breast Cancer Intratumoral Heterogeneity.

Authors:  Mei Zhang; Jeffrey M Rosen
Journal:  Trends Cancer       Date:  2015-12-01

7.  CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Authors:  Sulagna Banerjee; Alice Nomura; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Selwyn M Vickers; Ashok Saluja
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

8.  VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis.

Authors:  Tiffany N Seagroves; Danielle L Peacock; Debbie Liao; Luciana P Schwab; Robin Krueger; Charles R Handorf; Volker H Haase; Randall S Johnson
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

9.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

10.  Tumor biology and cancer therapy - an evolving relationship.

Authors:  Thomas Seufferlein; Johann Ahn; Denis Krndija; Ulrike Lother; Guido Adler; Götz von Wichert
Journal:  Cell Commun Signal       Date:  2009-08-13       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.